Impaired Signaling in Alloantigen-Specific CD8+ T Cells Tolerized in Vivo: Employing a Model of Ld-Specific TCR Transgenic Mice Transplanted with Allogenic Hearts under the Cover of a Short-Term Rapamycin Treatment

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4297-4308

  Chen, Huifang ^a   Luo, Hongyu ^a   Xu, Dasheng ^a   Loh, Dennis Y ^b   Daloze, Pierre M ^a   Veillette, André ^c   Qi, Shijie ^a   Wu, Jiangping ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b NIPPON ROCHE RESEARCH CENTER   (Japan)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; FYN PROTEIN, MOUSE; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B); IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIGEN RECEPTOR; ONCOPROTEIN; POLYENE; PROTEIN KINASE FYN; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; RAPAMYCIN;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; C57BL MOUSE; CD8+ T LYMPHOCYTE; DRUG EFFECT; ENZYMOLOGY; GENETICS; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOUSE; MOUSE STRAIN; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; H-2 ANTIGENS; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; POLYENES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; SIROLIMUS; SRC-FAMILY KINASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030588676     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Vezina, C., A. Kudelski, and S. N. Sehgal. 1975. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. (Tokyo) 28:721.
2. Harding, M. W., A. Galat, D. E. Uehling, and S. L. Schreiber. 1989. A receptor for the immunosuppressant FK506 is a cis-trans peptidylprolyl isomerase. Nature 341:758.
3. Chen, H., H. Luo, P. Daloze, D. Xu, and J. Wu. 1994. Rapamycin-induced long-term allograft survival depends on persistence of alloantigen. J. Immunol. 152: 3107.
4. Calne, R. Y., D. St. J. Collier, S. Lim, S. G. Pollard, A. Samaan, D. J. G. White, and S. Thiru. 1989. Rapamycin for immunosuppression in organ allografting. Lancet 2:227.
5. Hall, B. M., M. E. Jelbart, and S. E. Dorsch. 1984. Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Transplantation 37:595.
6. Miyagawa, S., J. G. Lawen, S. M. Stepkowski, and B. D. Kahan. Cyclosporine induces reduction of antigen-specific T cytotoxic clones in rats transplanted with heart allografts. Transplant. Proc. 23:485.
7. Ochiai, T., K. Nakajima, M. Nagata, S. Hori, T. Asano, and K. Isono. 1987. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 44:734.
8. Wood, M. J., D. J. Sloan, M. J. Dallman, and H. M. Charlton. 1993. Specific tolerance to neural allografts induced with an antibody to the interleukin 2 receptor. J. Exp. Med. 177:597.
9. Chen, Z., S. Cobbold, S. Metcalfe, and H. Waldmann. 1992. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur. J. Immunol. 22:805.
10. Isobe, M., H. Yagita, K. Okumura, and A. Ihara. 1992. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255:1125.
11. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
12. Ramsdell, F., and B. J. Fowlkes. 1992. Maintenance of in vivo tolerance by persistence of antigen. Science 257:1130.
13. Stitz, L. 1992. Induction of antigen-specific tolerance by cyclosporin A. Eur. J. Immunol 22:1995.
14. Morecki, S., B. Leshem, A. Eid, and S. Slavin. 1987. Alloantigen persistence in induction and maintenance of transplantation tolerance. J. Exp. Med. 165:1468.
15. Feldmann, M., C. H. June, A. McMichael, R. Maini, E. Simpson, and J. N. Woody. 1992. T-cell-targeted immunotherapy. Immunol. Today 13:84.
16. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335:271.
17. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine TS polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
18. lck in response to activators of protein kinase C. Oncogene Res. 2:385.
19. fyn. J. Exp. Med. 175:1483.
20. Corry, R. J., H. J. Winn, and P. S. Russell. 1973. Heart transplantation in congenic strains of mice. Transplant. Proc. 5:733.
21. Luo, H., W. Duguid, H. Chen, M. Maheu, and J. Wu. 1994. The effect of rapamycin on T cell development in mice. Eur. J. Immunol. 24:692.
22. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1991. In vitro assays for mouse B and T cell function. In Current Protocols in Immunology, Ch. 3. John Wiley and Sons, New York, pp. 3.0.1-3.6.18.
23. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
24. -/- mice. J. Immunol. 155:3727.
25. Aguila, H. L., R. J. Hershberger, and I. L. Weissman. 1995. Transgenic mice carrying the diphtheria toxin A chain gene under the control of the granzyme A promoter: expected depletion of cytotoxic cells and unexpected depletion of CD8 T cells. Proc. Natl. Acad. Sci. USA 92:10192.
26. Morris, R. E. 1992. Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplant. Rev. 6:39.
27. Schonrich, G., F. Momburg, M. Malissen, A. M. Schmitt-Verhulst, B. Malissen, G. J. Hammerling, and B. Arnold. 1992. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int. Immunol. 4:581.
28. Schonrich, G., U. Kalinke, F. Momburg, M. Malissen, A. M. Schmitt-Verhulst, B. Malissen, G. J. Hammerling, and B. Arnold. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65:293.
29. Gajewski, T. F., D. Qian, P. Fields, and F. W. Fitch. 1994. Anergic T-lymphocyte clones have altered inositol phosphate, calcium and tyrosine kinase signaling pathways. Proc. Natl. Acad. Sci. USA 91:38.
30. Blackman, M. A., T. H. Finkel, J. Kappler, J. Cambier, and P. Marrack. 1991. Altered antigen receptor signaling in anergic T cells from self-tolerant T-cell receptor beta-chain transgenic mice. Proc. Natl. Acad. Sci. USA 88:6682.
31. Isakov, N., R. L. Wange, and L. E. Samelson. 1994. The role of tyrosine kinases and phosphotyrosine-containing recognition motifs in regulation of the T cell-antigen receptor-mediated signal transduction pathway. J. Leukocyte Biol. 55: 265.
32. Samelson, L. E., and R. D. Klausner. 1992. Tyrosine kinases and tyrosine-based activation motifs: current research on activation via the T cell antigen receptor. J. Biol. Chem. 267:24913.
33. Mizoguchi, H., J. J. O'Shea, D. L. Longo, C. M. Loeffler, D. W. McVicar, and A. C. Ochoa. 1992. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795.
34. Salvadori, S., B. Bansbacher, A. M. Pizzimenti, and K. S. Zier. 1994. Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors. J. Immunol. 153:5176.
35. Veillette, A., and D. Davidson. 1992. Src-related protein tyrosine kinases and T-cell receptor signaling: tyrosine phosphorylation pathways. Trends Genet. 8:61.
36. Alferink, J., B. Schittek, G. Schonrich, G. J. Hammerling, and B. Arnold. 1995. Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance. Int. Immunol. 7:331.
37. Nathan, P. 1964. Antigen release from the transplanted dog kidney. Ann. NY Acad. Sci. 120:458.
38. Vetto, R. M., and D. R. Burger. 1972. Endothelial cell stimulation of allogeneic lymphocytes. Transplantation 14:652.
39. Strober, S., and J. L. Gowans. 1965. The role of lymphocytes in the sensitization of rats to renal homografts. J. Exp. Med. 122:347.
40. Nemlander, A., A. Soots, E. Von Willebrand, B. Husberg, and P. Hayry. 1982. Redistribution of renal allograft-responding leukocytes during rejection. J. Exp. Med 156:1087.
41. Adams, P. W., H. S. Lee, W. J. Waldman, D. D. Sedmak, C. J. Morgan, J. S. Ward, and C. G. Orosz. 1982. Alloantigenicity of human endothelial cells. I. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells. J. Immunol. 148:3753.
42. Chen, H., S. Sehgal, P. Daloze, and J. Wu. 1995. Pretreatment of donors and grafts with rapamycin: the effect on graft survival and the tissue drug retention. Clin. Immunol. Immunopathol. 76:321.
43. Chen, H., D. Xu, S. Qi, J. Wu, H. Luo, and P. Daloze. 1995. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat. Transplantation 59:1084.
44. Witmer-Pack, M. D., W. Olivier, J. Valinsky, G. Schuler, and R. M. Steinman. 1987. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166:1484.
45. Heufler, C., F. Koch, and G. Schuler. 1988. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167:700.
46. Faustmann, D., V. Hauptfeld, P. Lacy, and J. Davie. 1982. Demonstration of active tolerance in maintenance of established islet of Langerhans allografts. Proc. Nat. Acad. Sci. USA 79:4153.
47. Larsen, C. P., P. J. Morris, and J. M. Austyn. 1990. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J. Exp. Med. 171:307.
48. Rocha, B., C. Tanchot, and H. Von Boehmer. 1993. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177:1517.
49. Rush, D. N., J. R. Jeffery, and J. Gough. 1995. Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 59:511.
50. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.